SCHEMBL8041330

SCHEMBL8041330

COc1cc(Cl)c(C(=O)N(C)C(=O)NCC(F)(F)F)c([N+](=O)[O-])c1O

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
G6PD P11413 1/20 0.34
CRHBP P24387 1/20 0.34
CRHR2 Q13324 1/20 0.34
TTR P02766 1/20 0.33
ERN1 O75460 1/20 0.33
MAPT P10636 4/20 0.33
KMT2A Q03164 4/20 0.33
MCL1 Q07820 1/20 0.33
EGFR P00533 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
COMT P21964 1/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
POLB P06746 2/20 0.32
TDP1 Q9NUW8 2/20 0.32
KDM4E B2RXH2 1/20 0.32
CTDSP1 Q9GZU7 1/20 0.32
ALDH1A1 P00352 1/20 0.32
HTT P42858 1/20 0.32
PTPN1 P18031 1/20 0.32
MEN1 O00255 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8038161 0.88 ERN1 (0.38) G6PDCRHBPCRHR2ERN1MAPT
SCHEMBL8041625 0.86 EGFR (0.35) G6PDCRHBPCRHR2ERN1MAPT
SCHEMBL8040095 0.84 ERN1 (0.37) G6PDCRHBPCRHR2ERN1MAPT
SCHEMBL8035153 0.82 TRPV1 (0.41) EGFR
SCHEMBL8028329 0.82 G6PD (0.37) G6PDCRHBPCRHR2TTRMAPT
SCHEMBL8035729 0.81 PTPN1 (0.37) G6PDCRHBPCRHR2MAPTKMT2A
SCHEMBL8041338 0.80 KMT2A (0.45) MAPTKMT2AEGFRPOLBKDM4E
SCHEMBL8041385 0.78
SCHEMBL8028100 0.77 L3MBTL1 (0.35) G6PDCRHBPCRHR2ERN1MAPT
SCHEMBL8028096 0.76 TDP1 (0.35) G6PDCRHBPCRHR2TTRERN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009081892-A1 NOVEL CATECHOL DERIVATIVE, PHARMACEUTICAL COMPOSITION CONTAINING THE SAME, AND USE OF THOSE KISSEI PHARMACEUTICAL CO., LTD. (JP) 2009-07-02 WO disclosed